Inventor · disambiguated record
Jimmy Andrew Rotolo
Also filed as: ROTOLO JIMMY · ROTOLO JIMMY ANDREW
13 granted patents·9 pending applications·21 citations·filing 2008–2024
89Inventor score
Files withSAPIENCE THERAPEUTICS INC6SLOAN KETTERING INST CANCER RES5MEMORIAL SLOAN KETTERING CANCER CENTER4CONTRAFECT CORP3ROTOLO JIMMY ANDREW3
Top patents by PatentIndex Score
22 records- 0190US12208131B2ATF5 peptide variants and uses thereofSAPIENCE THERAPEUTICS INC·Filed 2023·Granted Jan 28, 2025·1 cites·8 claims
- 0289US2025325559A1Methods for treating gi syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2024·Application pending·0 cites
- 0387US10450385B2Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Oct 22, 2019·3 cites·4 claims
- 0485US9499594B2Biofilm prevention, disruption and treatment with bacteriophage lysinCONTRAFECT CORP·Filed 2013·Granted Nov 22, 2016·6 cites·20 claims
- 0585US2025197524A1Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 0682US8562993B2Methods for treating GI syndrome and graft versus host diseaseROTOLO JIMMY ANDREW·Filed 2008·Granted Oct 22, 2013·4 cites·6 claims
- 0782US2025127849A1ATF5 Peptide Variants and Uses ThereofSAPIENCE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0881US10316077B2Cell-penetrating ATF5 polypeptides and uses thereofSAPIENCE THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2019·3 cites·20 claims
- 0980US12121525B2Methods for treating GI syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2021·Granted Oct 22, 2024·0 cites·4 claims
- 1080US11878047B2ATF5 peptide variants and uses thereofSAPIENCE THERAPEUTICS INC·Filed 2019·Granted Jan 23, 2024·1 cites·10 claims
- 1180US2023277617A1Biofilm prevention, disruption and treatment with bacteriophage lysinCONTRAFECT CORP·Filed 2022·Application pending·0 cites
- 1278US11207329B2Methods for treating GI syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2018·Granted Dec 28, 2021·1 cites·6 claims
- 1378US2023416409A1Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 1477US10525100B2ATF5 peptide variants and uses thereofSAPIENCE THERAPEUTICS INC·Filed 2019·Granted Jan 7, 2020·1 cites·9 claims
- 1575US11447572B2Anti-ceramide antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Sep 20, 2022·0 cites·13 claims
- 1672US11524046B2Biofilm prevention, disruption and treatment with bacteriophage lysinCONTRAFECT CORP·Filed 2019·Granted Dec 13, 2022·0 cites·43 claims
- 1772US9592238B2Anti-ceramide monoclonal antibody 2A2ROTOLO JIMMY ANDREW·Filed 2013·Granted Mar 14, 2017·1 cites·8 claims
- 1861US10722577B2Methods for treating GI syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2013·Granted Jul 28, 2020·0 cites·9 claims
- 1959US2022118087A1Methods for treating gi syndrome and graft versus host diseaseSLOAN KETTERING INST CANCER RES·Filed 2020·Application pending·0 cites
- 2058US2017273987A1Methods for Treating GI Syndrome and Graft versus Host DiseaseROTOLO JIMMY ANDREW·Filed 2017·Application pending·0 cites
- 2155US2017127683A1Biofilm prevention, disruption and treatment with bacteriophage lysinSCHUCH RAYMOND·Filed 2016·Application pending·0 cites
- 2252US2023218717A1Administration of CEBP-Beta Antagonist and Methods of UseSAPIENCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →